(2023) Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation. Nat Immunol 24(2), 295-308.
Prof. Dr. Gianni PanagiotouMicrobiome Dynamics · Head +49 3641 532-1759 firstname.lastname@example.org
Main Research Areas
- Medical & Environmental Metagenomics: human, mice, marine, plants;
- Systems Biology: -omics integration, chemical-protein & protein-protein interaction networks;
- Synthetic Biology: genome-scale metabolic modelling, design of probiotics, discovery of postbiotics
(2023) Disruption of the A. fumigatus RNA interference machinery alters the conidial transcriptome. RNA [Epub ahead of print]
(2023) Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions. Nat Commun 14(1), 2673.
(2022) From environmental adaptation to host survival: Attributes that mediate pathogenicity of Candida auris. Virulence 13(1), 191-214.
(2022) Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity. Nat Commun 13(1), 3192.
(2022) Candida albicans SR-like protein kinases regulate different cellular processes: Sky1 is involved in control of ion homeostasis, while Sky2 is important for dipeptide utilization. Front Cell Infect Microbiol 12, 850531.
(2022) Potential of microbiome-based solutions for agrifood systems. Nature Food 3, 557-560. (Review)
(2022) Risk assessment with gut microbiome and metabolite markers in NAFLD development. Sci Transl Med 14(648), eabk0855.
(2022) Inhibitors of ApiAP2 protein DNA binding exhibit multistage activity against Plasmodium parasites. PLOS Pathog 18(10), e1010887.